Jump to content

Andreas Strüngmann

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 178.11.0.43 (talk) at 03:36, 16 September 2020 (Category:20th-century German businesspeople Category:21st-century German businesspeople). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Andreas Strüngmann (born 1950) is a German businessman and founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer.[1] In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion,[2] making Sandoz the largest generic-drug company in the world.

He currently has residences in Tegernsee and South Africa and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis.

See also

References

  1. ^ Timmons, Heather & Wright, Tom. "Novartis to Buy Two Makers of Generics". The New York Times, 22 February 2005. Retrieved on 27 May 2013.
  2. ^ Forbes. "Andreas Strungmann - Forbes". March 2013. Retrieved on 27 May 2013.
Stub icon

This German business-related biographical article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Andreas_Strüngmann&oldid=978639125"